Trial · NCT00565851
Participant flow88
How many started, completed or left each group, period by period.
1 to 20 of 88
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Surgical Assignment | STARTED | Arm I (no Surgery; Carboplatin and Paclitaxel) | 316 | |
| Surgical Assignment | STARTED | Arm II (no Surgery; Carboplatin, Paclitaxel and Bevacizumab) | 456 | |
| Surgical Assignment | STARTED | Arm III (Surgery; Carboplatin and Paclitaxel) | 33 | |
| Surgical Assignment | STARTED | Arm IV (Surgery; Carboplatin, Paclitaxel and Bevacizumab) | 165 | |
| Surgical Assignment | STARTED | Arm V (no Surgery; Carboplatin and Gemcitabine) | 6 | |
| Surgical Assignment | STARTED | Arm VI (no Surgery; Carboplatin, Gemcitabine and Bevacizumab) | 34 | |
| Surgical Assignment | STARTED | Arm VII (Surgery; Carboplatin and Gemcitabine) | 5 | |
| Surgical Assignment | STARTED | Arm VIII (Surgery; Carboplatin, Gemcitabine and Bevacizumab) | 37 | |
| Surgical Assignment | Randomized - Yes Surgery | Arm I (no Surgery; Carboplatin and Paclitaxel) | 0 | |
| Surgical Assignment | Randomized - Yes Surgery | Arm II (no Surgery; Carboplatin, Paclitaxel and Bevacizumab) | 0 | |
| Surgical Assignment | Randomized - Yes Surgery | Arm III (Surgery; Carboplatin and Paclitaxel) | 33 | |
| Surgical Assignment | Randomized - Yes Surgery | Arm IV (Surgery; Carboplatin, Paclitaxel and Bevacizumab) | 165 | |
| Surgical Assignment | Randomized - Yes Surgery | Arm V (no Surgery; Carboplatin and Gemcitabine) | 0 | |
| Surgical Assignment | Randomized - Yes Surgery | Arm VI (no Surgery; Carboplatin, Gemcitabine and Bevacizumab) | 0 | |
| Surgical Assignment | Randomized - Yes Surgery | Arm VII (Surgery; Carboplatin and Gemcitabine) | 5 | |
| Surgical Assignment | Randomized - Yes Surgery | Arm VIII (Surgery; Carboplatin, Gemcitabine and Bevacizumab) | 37 | |
| Surgical Assignment | Randomized - no Surgery | Arm I (no Surgery; Carboplatin and Paclitaxel) | 33 | |
| Surgical Assignment | Randomized - no Surgery | Arm II (no Surgery; Carboplatin, Paclitaxel and Bevacizumab) | 172 | |
| Surgical Assignment | Randomized - no Surgery | Arm III (Surgery; Carboplatin and Paclitaxel) | 0 | |
| Surgical Assignment | Randomized - no Surgery | Arm IV (Surgery; Carboplatin, Paclitaxel and Bevacizumab) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00565851/flow